脂质体稳定性:多因素调节和优化策略 in in vivo 交付
Xiao-Si Lu1,2,3, Li-Qing Yang1,2,3, Lan Ma2,4
1Third-grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional Chinese Medicine, China Three Gorges University, Yichang, China.
Journal of liposome research
|September 22, 2025
概括
脂质体的稳定性对于有效和安全的药物输送至关重要. 本研究详细介绍了影响活体脂质体的因素,以及为未来药物开发提高其稳定性的策略.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 纳米技术 纳米技术
背景情况:
- 脂质体是药物输送系统中的重要载体,但它们的体内稳定性对于治疗效率和安全性至关重要.
- 在体内,脂质体的稳定性受到固有的特性和复杂的生物环境的影响.
- 了解这些因素对于成功开发基于脂质体的药物至关重要.
研究的目的:
- 阐明脂质体在体内的旅程,包括循环,分布,新陈代谢和分泌.
- 总结影响脂质体稳定性的生物学因素,如免疫反应和蛋白质相互作用.
- 探索提高脂质体稳定性的策略,以改善药物输送.
主要方法:
- 对生物系统中的脂质体行为进行审查.
- 对影响脂质体完整性的生物因素的分析.
- 探索配方和修改技术以提高稳定性.
主要成果:
- 脂质体的稳定性受到免疫识别,蛋白质-脂质相互作用,酶降解和生理变化的挑战.
- 优化脂质组成和表面修饰是提高稳定性的关键策略.
- 人工智能辅助开发和生物相容材料是未来的方向.
结论:
- 脂质体稳定性是一个多方面的问题,受生物相互作用和配方的影响.
- 通过战略设计和材料选择,可以实现更高的稳定性.
- 未来的研究应该专注于人工智能集成和新生物相容材料,用于先进的脂质体药物输送.
更多相关视频
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
200
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
200
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
507
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
507
Bioavailability Enhancement: Drug Permeability Enhancement
188
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
188
Bioavailability Enhancement: Drug Solubility Enhancement
223
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
223
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
189
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
189
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
3.1K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
3.1K


